Your browser is no longer supported. Please, upgrade your browser.
AGRX Agile Therapeutics, Inc. monthly Stock Chart
AGRX [NASD]
Agile Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.01 Insider Own13.89% Shs Outstand29.40M Perf Week-9.38%
Market Cap68.21M Forward P/E- EPS next Y-1.21 Insider Trans0.00% Shs Float26.88M Perf Month-66.23%
Income-27.40M PEG- EPS next Q-0.28 Inst Own86.40% Short Float1.17% Perf Quarter-66.81%
Sales- P/S- EPS this Y2.30% Inst Trans-1.63% Short Ratio0.57 Perf Half Y-65.17%
Book/sh1.62 P/B1.43 EPS next Y-5.20% ROA-40.30% Target Price10.42 Perf Year-67.14%
Cash/sh1.76 P/C1.32 EPS next 5Y- ROE-57.50% 52W Range1.82 - 8.65 Perf YTD-59.30%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-73.18% Beta-
Dividend %- Quick Ratio6.50 Sales past 5Y- Gross Margin- 52W Low27.47% ATR0.37
Employees18 Current Ratio6.50 Sales Q/Q- Oper. Margin- RSI (14)12.07 Volatility5.94% 11.04%
OptionableNo Debt/Eq0.33 EPS Q/Q35.80% Profit Margin- Rel Volume0.33 Prev Close2.37
ShortableYes LT Debt/Eq0.26 EarningsFeb 06 AMC Payout- Avg Volume556.74K Price2.32
Recom1.50 SMA20-44.89% SMA50-60.23% SMA200-65.65% Volume180,820 Change-2.11%
Jan-08-16Initiated Cantor Fitzgerald Buy
Apr-02-15Initiated FBR Capital Outperform $17
Jun-17-14Initiated William Blair Outperform
Jun-17-14Initiated RBC Capital Mkts Outperform $12
Jan-20-17 09:08PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
08:10PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Agile Therapeutics, Inc. and Certain Officers AGRX GlobeNewswire
05:21PM  CRUCIAL SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
02:19PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Agile Therapeutics, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
Jan-19-17 04:15PM  Agile Therapeutics to Present at Noble Capital Markets Thirteenth Annual Investor/Equity Conference GlobeNewswire
Jan-18-17 05:03PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
02:30PM  AGILE THERAPEUTICS LOSS NOTICE: Rosen Law Firm Reminds Investors of Important Class Action Deadline AGRX Business Wire
11:42AM  Lifshitz & Miller Law Firm Announces Investigation of Abeona Therapeutics Inc., Agile Therapeutics, Inc., Alere Inc., Floteck Industries, Inc., Insys Therapeutics Inc., MTS Systems Corporation, Ophthotech Corporation and Teekay Corporation PR Newswire
Jan-17-17 12:11PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
11:36AM  AGRX INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Agile Therapeutics, Inc. and a Lead Plaintiff Deadline of March 7, 2017 GlobeNewswire
06:55AM  IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
04:00AM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Jan-16-17 10:16AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) and Lead Plaintiff Deadline: March 7, 2017 Accesswire
Jan-14-17 01:53PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Jan-13-17 05:24PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
04:14PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $50,000 Investing In Agile Therapeutics, Inc. To Contact The Firm Before Lead Plaintiff Deadline GlobeNewswire
Jan-12-17 08:29PM  IMPORTANT SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
08:00PM  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Agile Therapeutics, Inc. (AGRX) To Contact Brower Piven Before The Lead Plaintiff Deadl GlobeNewswire
Jan-11-17 04:29PM  Robbins Arroyo LLP: Agile Therapeutics, Inc. (AGRX) Misled Shareholders According to a Recently Filed Class Action Business Wire
01:37PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) and Lead Plaintiff Deadline: March 7, 2017 GlobeNewswire
09:00AM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Jan-10-17 08:00PM  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Agile Therapeutics, Inc. (AGRX) GlobeNewswire
05:45PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Agile Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 7, 2017 AGRX GlobeNewswire
05:41PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
03:40PM  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Agile Therapeutics, Inc. Marketwired
02:10PM  IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces a Class Action Lawsuit Against Agile Therapeutics, Inc. and Advises Investors with Losses to Contact the Firm Business Wire
01:26PM  The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Agile Therapeutics, Inc. Investors and Encourages Investors to Contact the Firm Business Wire
08:45AM  AGILE (AGRX) ALERT: Johnson & Weaver, LLP Announces Filing of Class Action Complaint Against Agile Therapeutics, Inc.; Encourages all Investors to Contact the Firm for Information PR Newswire
Jan-09-17 05:16PM  Harwood Feffer LLP Announces Investigation of Agile Therapeutics, Inc. PR Newswire
03:16PM  AGILE NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $50,000 Investing In Agile Therapeutics, Inc. To Contact The Firm PR Newswire
12:50PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Agile Therapeutics, Inc. AGRX Business Wire
11:37AM  IMPORTANT AGILE THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP notifies investors that a securities class action lawsuit has been filed on behalf of shareholders of Agile Therapeutics, Inc. in the District of N GlobeNewswire
10:15AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) and Lead Plaintiff Deadline: March 7, 2017 PR Newswire
08:03AM  AGILE THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, F
Jan-07-17 09:50AM  4 Companies That Destroyed Shareholders Last Week
Jan-06-17 04:30PM  Glancy Prongay & Murray LLP Files Securities Class Action Lawsuit Against Agile Therapeutics, Inc. Business Wire +6.75%
Jan-05-17 01:54PM  IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Agile Therapeutics, Inc. and Advises Investors with Losses to Contact the Firm Business Wire
01:52PM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Agile Therapeutics, Inc. Investors Business Wire
Jan-04-17 06:15PM  INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Agile Therapeutics, Inc. Investors Business Wire -47.40%
04:04PM  DryShips, Agile Therapeutics in Wednesdays 52-Week Low Club
03:16PM  How a Birth Control Patch Hurt Agile Therapeutics' Stock
03:11PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Agile Therapeutics, Inc. (AGRX) PR Newswire
01:55PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agile Therapeutics, Inc. - AGRX PR Newswire
12:15PM  Wednesdays Top 5 Biopharma Movers
11:54AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violations of Federal Securities Laws by Certain Officers and Directors of Agile Therapeutics, Inc. Business Wire
10:05AM  Dow inches toward 20,000 handle as stock market climbs at MarketWatch
08:10AM  Heres Why Apple, Tesla, and Three Other Stocks Are Trending at Insider Monkey
Jan-03-17 05:10PM  Agile Therapeutics shares plummet after contraceptive study data at MarketWatch -12.28%
05:05PM  AGILE THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:11PM  Agile Therapeutics Announces Positive Top-line Phase 3 Results GlobeNewswire
Dec-22-16 08:00AM  Agile Therapeutics to Present at Biotech Showcase 2017 GlobeNewswire
07:30AM  Agile Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-18-16 10:16PM  How Agile Therapeutics Inc (AGRX) Stacks Up Against Its Peers at Insider Monkey
Dec-15-16 10:34AM  Agile Therapeutics, Inc. :AGRX-US: Earnings Analysis: Q3, 2016 By the Numbers : December 15, 2016
Dec-02-16 04:40PM  Immunomedics, Inc. (IMMU): The Smart Money Is Quietly Loading Up On This Stock at Insider Monkey
Dec-01-16 08:16AM  AGILE THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:00AM  Agile Therapeutics Receives Approximately $3 Million in Non-Dilutive Funding from New Jerseys Technology Business Tax Certificate Transfer Program GlobeNewswire
Nov-17-16 01:04PM  AGILE THERAPEUTICS INC Financials
Nov-07-16 06:18PM  Agile Therapeutics reports 3Q loss
04:45PM  AGILE THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
04:10PM  Agile Therapeutics Reports Third Quarter 2016 Financial Results and Announces Completion of Subject Visits for Twirla® Phase 3 SECURE Clinical Trial GlobeNewswire
Oct-11-16 02:36PM  Agile Therapeutics, Inc. :AGRX-US: Earnings Analysis: Q2, 2016 By the Numbers : October 11, 2016
Oct-06-16 05:09PM  AGILE THERAPEUTICS INC Files SEC form 8-K, Other Events
Aug-31-16 04:21PM  3 Clinical-Stage Biotech Stocks With News About To Break at Motley Fool
Aug-26-16 04:32PM  AGILE THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial
Aug-08-16 05:11PM  Agile Therapeutics reports 2Q loss
04:12PM  AGILE THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
04:05PM  Agile Therapeutics Reports Second Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q2 2016 Agile Therapeutics Inc Earnings Release - After Market Close
Jul-28-16 04:32PM  AGILE THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Finan
04:11PM  Agile Therapeutics Appoints Seth H. Z. Fischer to its Board of Directors GlobeNewswire
Jul-21-16 08:42AM  Why Agile Therapeutics (AGRX) Stock Might be a Great Pick
Jul-13-16 08:32AM  AGILE THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jul-12-16 04:12PM  Agile Therapeutics Announces Plans to Advance Contraceptive Pipeline GlobeNewswire
Jul-06-16 04:32PM  AGILE THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Stateme
04:15PM  Agile Therapeutics Strengthens Executive Leadership Team with New Chief Commercial Officer GlobeNewswire
Jun-23-16 04:10PM  Agile Therapeutics to Present at the Cantor Fitzgeralds 2nd Annual Healthcare Conference GlobeNewswire +5.81%
Jun-16-16 08:00AM  Agile Therapeutics Announces Issuance of Patent for Progestin Patch Designs GlobeNewswire
Jun-08-16 04:17PM  AGILE THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -5.45%
Jun-07-16 06:21PM  3 Biotech Stocks Billionaires Are Buying That I'm Buying, Too at Motley Fool
08:00AM  Agile Therapeutics to Present at the William Blair & Companys 36th Annual Growth Stock Conference GlobeNewswire
Jun-06-16 02:26PM  Agile Therapeutics, Inc. :AGRX-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016
Jun-02-16 05:16PM  Agile Therapeutics to Present at the Jefferies 2016 Healthcare Conference GlobeNewswire
May-31-16 05:44PM  These Billionaires Just Made a Killing on Celator. Here's What Else They've Been Buying at Motley Fool
08:52AM  Can Agile Therapeutics (AGRX) Run Higher on Strong Earnings Estimate Revisions?
May-09-16 06:18PM  Agile Therapeutics reports 1Q loss
05:06PM  AGILE THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
04:10PM  Agile Therapeutics Reports First Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q1 2016 Agile Therapeutics Inc Earnings Release - After Market Close
Apr-18-16 04:31PM  AGILE THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
Apr-15-16 08:00AM  Agile Therapeutics to Present at Womens Health 2016: The 24th Annual Congress GlobeNewswire
Mar-30-16 04:10PM  Agile Therapeutics to Present at the 15th Annual Needham Healthcare Conference GlobeNewswire
Mar-09-16 05:09PM  Agile Therapeutics reports 4Q loss
04:20PM  AGILE THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
04:10PM  Agile Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results GlobeNewswire
Mar-03-16 04:15PM  Agile Therapeutics to Present at the 28th Annual ROTH Conference GlobeNewswire
Feb-24-16 04:22PM  AGILE THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Finan
04:15PM  Agile Therapeutics Appoints Ajit S. Shetty, Ph.D., to Its Board of Directors GlobeNewswire
Feb-16-16 04:15PM  Agile Therapeutics to Present at the 2016 RBC Capital Markets Global Healthcare Conference GlobeNewswire
Agile Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, a once-weekly contraceptive patch, which is in Phase III clinical development. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Moorin Jay10% OwnerJan 27Buy6.35393,7002,499,9955,062,363Jan 29 04:05 PM